Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
Oussalah
A
A
Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
Laurent
V
V
Bruot
O
O
Guéant
J-L
JL
Régent
D
D
Bigard
M-A
MA
Peyrin-Biroulet
L
L
D000328:Adult; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D003424:Crohn Disease / Q000097:blood* / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011498:Protein Precursors / Q000097:blood*; D012720:Severity of Illness Index; D013223:Statistics as Topic; D055815:Young Adult
D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D002097:C-Reactive Protein; D015740:Calcitonin Gene-Related Peptide